inno.N

Governance

With its governance made transparent, inno.N seeks to build further trust in all stakeholders.

  • Executive directors

    • Name

      Kwak Dal-won (Chairman)

      Date of Appointment

      2018.04.18

      Term

      ~2024.04.18 (2 Appointments)

      Date of Birth

      1960

      Gender

      Male

      Academic Background

      A master's degree at Sungkyunkwan University Graduate School of Marketing

      Career

      Manager of sales marketing of HK inno.N / Manager of production of HK inno.N
    • Name

      Seo Moo-jung

      Date of Appointment

      2020.09.24

      Term

      ~2023.09.24

      Date of Birth

      1969

      Gender

      Male

      Academic Background

      A master's degree at Korea University Graduate School of Economics

      Career

      Director of Arthur. D. Little
      KT Corporate center
      Management planning of SPC Group
      Manager of business management support of HK inno.N
    • Name

      Song Geun-seok

      Date of Appointment

      2022.03.25

      Term

      ~2025.03.25

      Date of Birth

      1967

      Gender

      Male

      Academic Background

      A doctor of Veterinary Medicine at Konkuk University

      Career

      Director of CJ CheilJedang Pharmaceutical Research Center
      Director of CJ Healthcare Clinical Development
      Current) Manager of R&D of HK inno.N

    Other non-commercial directors

    • Name

      Yoon Sang-hyun

      Date of Appointment

      2021.06.22

      Term

      ~2024.06.22

      Date of Birth

      1974

      Gender

      Male

      Academic Background

      A bachelor's degree at Seoul National University /
      A master's degree at Stanford University Graduate School of Management

      Career

      Director at Bain & Company / CEO of Kolmar Korea
      Current) Vice President of Kolmar Korea Holdings

    Outside director

    • Name

      Moon Beong-in

      Date of Appointment

      2020.09.24

      Term

      ~2023.09.24

      Date of Birth

      1962

      Gender

      Male

      Academic Background

      A doctor of Medicine at Seoul National University

      Career

      Director of Breast Cancer and Thyroid Cancer Center at Ewha Women's Cancer Hospital
    • Name

      Park Jae-seok

      Date of Appointment

      2020.09.24

      Term

      ~2023.09.24

      Date of Birth

      1975

      Gender

      Male

      Academic Background

      A doctor of trade at Hansung University

      Career

      Kim & Chang Law Office
    • Name

      Son Yeo-won

      Date of Appointment

      2021.03.25

      Term

      ~2024.03.25

      Date of Birth

      1959

      Gender

      Female

      Academic Background

      A doctor of pharmacology at Seoul National University

      Career

      Policy Advisory Committee member of the Ministry of Food and Drug Safety
      Professor of Pharmacy at Sungkyunkwan University
  • 2022
    No. Date Agenda Resolution
    Status
    Executive Director Non-executive Director Outside Director
    D.W. Kwak M.J. Seo S.W. Ahn B.I. Mun J.S Park Y.W. Son
    1 2022.01.14 Agenda No.1 : Appointment of Temporary chairman Resolved For For For For For For
    Agenda No.2 : Change of CEO Resolved For For For For For For
    2 2022.02.09 Reporting No1. : Internal accounting control system opertating status reporting - - - - - - -
    Agenda No.1 : Declaration of introduction ISO37301 and Appointment of Compliance officer Resolved For For For For For For
    Agenda No.2 : Appointment of an autonomous compliance manager Resolved For For For For For For
    Agenda No.3 : Approval of the 8th financial statements and business report Resolved For For For For For For
    Agenda No.4 : Adoption of the electronic voting system Resolved For For For For For For
    Agenda No.5 : Approval of the bank loan Resolved For For For For For For
    Agenda No.6 : Decision of Conclusion of Stock Repurchase Trust Contract Resolved For For For For For For
    3 2022.03.10 Reporting No.1 : Compliance officers' activity report - - - - - - -
    Agenda No.1 : Approval of safety and health plans Resolved For For For For For For
    Agenda No.2 : Approval of Compliance policy Resolved For For For For For For
    Agenda No.3 : Decision of cash dividend Resolved For For For For For For
    Agenda No.4 : Convene the 8th annual stockholders' meeting Resolved For For For For For For
    2021
    No. Date Agenda Resolution
    Status
    Executive Director Non-executive Director Outside Director
    S.H. Kang S.H. Yun D.W. Kwak M.J. Seo H.J. Kim S.W. Ahn J.H Chae S.H. Yun B.I. Mun J.S Park Y.W. Son M.Y. Yu
    1 2021.01.08 Agenda No.1 : The establishment of disclosure management regulation Resolved For For For For For For For - For For - For
    Agenda No.2 : Approval of the bank loan Resolved For For For For For For For - For For - For
    2 2021.02.09 Reporting No.1 : Business reporting - - - - - - - - - - - - -
    Reporting No.2 : Internal accounting control system operating status reporting - - - - - - - - - - - - -
    Reporting No.3 : Appointment of the 8th external auditor - - - - - - - - - - - - -
    Agenda No.1 : Approval of the 7th financial statements Resolved For For For For For For For - For For - For
    3 2021.03.10 Reporting No.1 : Internal accounting control system operating status reporting - - - - - - - - - - - - -
    Agenda No.1 : Convene the 7th annual stockholders' meeting Resolved For For For For For For For - For For - For
    Agenda No.2 : Establishment of code of donduct to be approved and Appointment of compliance assistant Resolved For For For For For For For - For For - For
    Agenda No.3 : Approval of the establishment of health and safety rules Resolved For For For For For For For - For For - For
    4 2021.03.25 Agenda No.1 : Change of CEO Resolved For For For For For For For - For For For -
    5 2021.04.21 Agenda No.1 : The issue of new shares for a third party Resolved For For For For For For For - For For For -
    Agenda No.2 : Approval of listing KOSDAQ Resolved For For For For For For For - For For For -
    6 2021.05.18 Agenda No.1 : Appointment of Members of Committee Resolved For For For For - - - - For For For -
    Agenda No.2 : Approval of the bank loan Resolved For For For For - - - - For For For -
    7 2021.06.22 Agenda No.1 : Convene the Extraordinary stockholders' meeting Resolved For For For For - - - - For For For -
    Agenda No.2 : Partial change of articles of Internal accounting management regulation Resolved For For For For - - - - For For For -
    8 2021.06.25 Agenda No.1 : Approval of the issue of new shares for listing KOSDAQ Resolved For - For For - - - For For For For -
    9 2021.06.25 Reporting No.1 : The result of ISO37001 Resolved - - - - - - - - - - - -
    Agenda No.1 : Approval of the construction of New laboratory at Pangyo Resolved For - For For - - - For For For For -
    Agenda No.2 : Approval of financing Resolved For - For For - - - For For For For -
    10 2021.12.21 Agenda No.1 : The establishment of inside information management regulation Resolved For - For For - - - For For For For -
    Agenda No.2 : The establishment of corporate governance charter Resolved For - For For - - - For For For For -
    2020
    No. Date Agenda Resolution
    Status
    Executive Director Non-commercial directors Outside Director
    S.H. Kang S.H. Yun D.W. Kwak B.H. Lee M.J. Seo H.J. Kim S.W. Ahn J.H Chae B.I. Mun J.S Park M.Y. Yu
    1 2020.01.23 Agenda No.1 :Approval of the issuance of corporate bonds Resolved For For For For - For For For - - -
    Agenda No.2 :Summoning of a temporary general shareholders’ meeting Resolved For For For For - For For For - - -
    Agenda No.3 :Approval of the lead investment bank that would be handling the IPO Resolved For For For For - For For For - - -
    Agenda No.4 :Approval of credit line with banks Resolved For For For For - For For For - - -
    2 2020.02.06 Reporting No.1 : Approval of financial statements for the 6th year - - - - - - - - - - - -
    Reporting No.2 : Report on operation of internal accounting rules - - - - - - - - - - - -
    Agenda No.1 :Approval of the conversion of excess proceeds from IPO into increased in capital without consideration Resolved For For For For - For For For - - -
    3 2020.02.24 Agenda No.1 :Change of common stock to type 1 redeemable convertible preferred stock (RCPS) and signing of agreement Resolved For For For For - For For For - - -
    Agenda No.2 :Approval of the agreement on merger Resolved For For For For - For For For - - -
    Agenda No.3 :Summoning of a temporary general shareholders’ meeting Resolved For For For For - For For For - - -
    4 2020.03.06 Reporting No.1 : Report on the audit opinion on the operation of internal accounting rules - - - - - - - - - - - -
    Agenda No.1 :Summoning of 6th regular general shareholders’ meeting Resolved For For For For - For For For - - -
    Agenda No.2 :Approval of listing on the stock exchange Resolved For For For For - For For For - - -
    5 2020.04.02 Agenda No.1 :Approval of public notice in lieu of general shareholders’ meeting to report on merger Resolved For For For For - For For For - - -
    6 2020.05.08 Agenda No.1 :Approval of revision of anti-corruption policies (ISO37001) and ex post facto review Resolved For For For For - For For For - - -
    Agenda No.2 :Approval of financial agreements Resolved For For For For - For For For - - -
    Agenda No.3 :Change of members to the audit committee Resolved For For For For - For For For - - -
    Agenda No.4 :Approval of credit line with banks Resolved For For For For - For For For - - -
    7 2020.08.13 Agenda No.1 :Approval of credit line with banks Resolved For For For For - For For For - - -
    8 2020.09.07 Agenda No.1 :Summoning of a temporary general shareholders’ meeting Resolved For For For For - For For For - - -
    9 2020.09.24 Agenda No.1 : Convene the Extraordinary stockholders' meeting Resolved For For For For - For For For - - -
    10 2020.09.24 Agenda No.1 :Summoning of a temporary general shareholders’ meeting Resolved For For For For - For For For For For For
    Agenda No.2 :Approval of establishment of a committee to recommend outside director candidates, appointment of committee members and operational rules Resolved For For For - For For For For For For For
    Agenda No.3 :Approval of establishment of Internal Transaction Committee, appointment of committee members and operational rules Resolved For For For - For For For For For For For
    Agenda No.4 :Revision of rules for the Board of Directors Resolved For For For - For For For For For For For
    Agenda No.5 :Dissolution of the Appointment Committee and absolution of operational rules Resolved For For For - For For For For For For For
    Agenda No.6 :Absolution of rules concerning joint CEOs Resolved For For For - For For For For For For For
    11 2020.11.11 Reporting No.1 : Report on the management review of anti-corruption management system - - - - - - - - - - - -
    Agenda No.1 :Approval of the changes to members of the Compensation Committee Resolved For For For - For For For For For For For
    2019
    No. Date Agenda Resolution
    Status
    Executive Director Outside Director
    S.H. Kang S.H. Yun D.W. Kwak B.H. Lee H.J. Kim S.W. Ahn J.H Chae
    1 2019.01.24 Agenda No.1 :Approval of establishment of an Auditor Appointment Committee Resolved For For For For For For For
    2 2019.02.08 Reporting No.1 : Report by CEO on the operation of the internal accounting rules - - - - - - - -
    Agenda No.1 :Approval of the 5th year financial statements Resolved For For For For For For For
    3 2019.03.08 Reporting No.1 : Report on the auditor’s opinion on the internal accounting rules - - - - - - - -
    Agenda No.1 :Summoning of the 5th regular general shareholders’ meeting Resolved For For For For For For For
    Agenda No.2 :Approval of credit line with banks Resolved For For For For For For For
    4 2019.04.15 Agenda No.1 :Summoning of a temporary general shareholders’ meeting Resolved For For For For For For For
    5 2019.05.24 Agenda No.1 :Approval of the issuance of corporate bonds Resolved For For For For For For For
    6 2019.06.28 Agenda No.1 :Approval of anti-corruption policies (ISO37001) Resolved For For For For For For For
    Agenda No.3 :Revision of rules concerning senior executives Resolved For For For For For For For
    7 2019.07.08 Agenda No.1 :Approval of investment in the new corporation Resolved For For For For For For For
    Agenda No.2 :Approval of capital increase in the Vietnamese affiliate Resolved For For For For For For For
    8 2019.10.23 Reporting No.1 : Report on the review of business management system for preventing corruption - - - - - - - -
    Agenda No.1 :Mid-term dividend payout to shareholders in 2019 Resolved For For For For For For For
  • Audit Committee

    Audit Committee

    Role

    The director's job execution, the company's business, the investigation of property status and the request for sales report to the management

    Chairman Jaeseok Park (outside director)
    Organization 3 outside Directors
    Member Park Jae-seok, Moon Beong-in, Son Yeo-won
    Acitiviti Details

    2021.02.09 Appointment of the external auditor

    2021.08.13 Examination of the yearly schedule of Internal accounting contro system

    2022.02.09 Internal accounting control system operating status reporting

    Outside Director Candidate Recommendation Committee

    Outside Director Candidate Recommendation Committee

    Role

    Establishing a process for recommending candidates for outside directors.

    Recommended by verifying the independence, diversity and competence.

    Chairman Moon Beong-in (Outside Director)
    Organization 3 outside Directors
    Member Moon Beong-in, Park Jae-seok, Son Yeo-won
    Acitiviti Details

    2021.03.03 Appointment of the chairman of Outside Director Candidate Recommendation Committee

    Internal Trade Committee

    Internal Trade Committee

    Role

    Improving transparency in transactions between subsidiaries and related parties.

    Chairman Son Yeo-won (Outside Director)
    Organization 3 outside Directors
    Member Son Yeo-won, Moon Beong-in, Park Jae-seok
    Acitiviti Details

    2021.12.21 Approval of internal transactions for year 2022

    Compensation committee

    Compensation Committee

    Role

    Evaluation of compensation policies and performance indicators for executives.

    Chairman  
    Organization 3 outside Directors
    Member Son Yeo-won, Moon Beong-in, Park Jae-seok
    Acitiviti Details

    -

  • category Adoption Note
    Adoption of the corporate governance charter O Established on December 21, 2021
    Establishment of employee ethics code O  
    Separation of the authority of CEO and BOD chair    
    Regular holding of BOD meetings O Regular BOD meetings are held four times a year
    Prior information given to directors when holding BOD meetings O  
    Adoption of rules concerning the role and procedures of BOD and committees O BOD rules; Rules for the Committee for the Recommendation of Outside Director Candidates
    Operation of a committee ensure recommendation of director candidates is given fairly O Operation of Committee for the Recommendation of Outside Director Candidates
    Public disclosure on the for/against voting results and attendance of directors at BOD meetings and key activities by BOD O  
    Insurance coverage of losses and damages for directors at the expense of the company O  
    Certification of the accuracy of business reports O Certification of CEO and senior executives handling daily corporate tasks
    Explanation on the differences from exemplary rules O  
TOP